Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Analytical Community Rewards Postnova System with 2012 Innovations Award

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
The new CF2000 Series for high-resolution separation and fractionation of nanoparticles has won the prestigious GIT Innovations Award 2012 in the category ‘Analytical Instrumentation and Software’.

The Postnova team are the inventors of the Field-Flow Fractionation (FFF) technique, and developed the CF2000 to be the first Centrifugal FFF system for routine use.

Dr Thorsten Klein, Founder and CEO, Postnova, said: “It is a great honour to receive this award. To be acknowledged by scientists working at the bench is particularly important for us as it shows that our innovative products are recognized as powerful practical tools for daily analysis, exactly what we designed them to be. I would like to thank the publishers at G.I.T. Verlag for sponsoring the award, the independent jury who placed the CF2000 on the shortlist and, most of all, everyone who took the time to vote for us online, at Analytica, and at Achema.”

The CF2000 is modular, allowing for a range of different detectors: Multi-Angle Light Scattering (MALS) , Dynamic Light Scattering (DLS) and Refractive Index (RI), for example, to be integrated. Whatever the configuration, everything from autosampler to detector is fully controlled by the NovaFFF software platform.
 
Importantly, by using a centrifugal field as the controlling force for the separation, particles are separated by Dynamic Diffusion on the basis of size and density. This novel approach allows discrimination of materials that have the same particle size but different densities.

The CF2000 has a wide operation range and is able to separate smaller species, such as proteins and polymers, from larger particles in one run with high resolution. The system is ideal for nanoparticles and works up into the microparticle size range too. No special sample treatment is necessary, allowing challenging biopharmaceutical, food-cosmetics, nanomaterial and environmental samples to be characterized.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!